How reliable is the Ki‐67 cytological index in grading pancreatic neuroendocrine tumors? A meta‐analysis
- 1 February 2016
- journal article
- research article
- Published by Wiley in Journal of Digestive Diseases
- Vol. 17 (2) , 95-103
Abstract
Objective: To investigate the accuracy of the cytological Ki‐67 index in distinguishing intermediate and high‐grade (G2 + G3) from low‐grade (G1) pancreatic neuroendocrine tumors (PNETs).Methods: Two investigators independently searched databases to identify eligible studies using the following term: (‘Ki‐67’) AND (‘pancreatic endocrine tumor’ OR ‘pancreatic neuroendocrine tumor’ OR ‘pancreatic endocrine tumour’ OR ‘pancreatic neuroendocrine tumour’ OR ‘pancreatic endocrine tumors’ OR ‘pancreatic neuroendocrine tumors’ OR ‘pancreatic endocrine tumours’ OR ‘pancreatic neuroendocrine tumours’), and meta‐analysis was performed to calculate the pooled sensitivity, specificity, positive (PLR) and negative likelihood ratio (NLR), and diagnostic odds ratio (DOR).Results: A total of 263 lesions from 13 studies were included in the study. The pooled sensitivity and specificity of Ki‐67 (cut‐off value: 2%) in the differential diagnosis of G2 + G3 from G1 PNETs were 64% and 87%, respectively. The pooled PLR, NLR and DOR were 3.96, 0.42 and 11.21, respectively. The area under the summary receiver operating characteristic curve (AUROC) was 0.8397. While the cut‐off value of Ki‐67 index was set as 5%, the sensitivity and specificity were increased up to 69% and 93%, respectively, and the AUROC was increased to 0.955.Conclusion: The cytological Ki‐67 index is very useful in distinguishing intermediate and high‐grade from low‐grade PNETs, and a cut‐off value of 5% had a better predictive value compared with that of 2%.Keywords
Funding Information
- National Natural Science Foundation of China (81472214, 81302070, 81101836)
This publication has 27 references indexed in Scilit:
- Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective studyGastrointestinal Endoscopy, 2012
- EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysisGastrointestinal Endoscopy, 2012
- Safety and Efficacy of Everolimus in Adult Patients with Neuroendocrine TumorsClinical Medicine Insights: Oncology, 2012
- The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumorsCancer Cytopathology, 2009
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic StratificationNeuroendocrinology, 2008
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumorsCancer, 2008
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative gradingEndocrine-Related Cancer, 2008
- Tumour biology and histopathology of neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Combining independent studies of a diagnostic test into a summary roc curve: Data‐analytic approaches and some additional considerationsStatistics in Medicine, 1993